X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.globenewswire.com/news-release/2024/04/22/2866529/0/en/Sandoz-confirms-European-Commission-approval-of-Pyzchiva-ustekinumab-further-strengthening-immunology-offering.html
https://www.pharmaceutical-technology.com/news/alvotech-teva-fda-selarsdi/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761343
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761044
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125261
https://www.fiercepharma.com/pharma/jj-settlement-biocon-biologics-gears-challenge-stelara-us
https://www.globenewswire.com//news-release/2024/02/15/2829780/0/en/Alvotech-Announces-Expected-Global-Market-Entry-Dates-for-AVT04-Biosimilar-to-Stelara-ustekinumab.html
https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-profit-estimates-pharmaceutical-unit-strength-2024-01-23/
https://www.globenewswire.com//news-release/2024/01/10/2806857/0/en/STADA-and-Alvotech-Secure-Approval-for-Uzpruvo-Europe-s-First-Ustekinumab-Biosimilar-to-Stelara.html
https://www.fiercepharma.com/pharma/jj-settlement-samsung-and-sandoz-lock-down-stelara-biosimilar-license
https://www.globenewswire.com//news-release/2023/11/14/2779894/0/en/Alvotech-and-JAMP-Pharma-Announce-Receipt-of-Marketing-Authorization-for-Jamteki-AVT04-the-First-Biosimilar-of-Stelara-ustekinumab.html
https://www.globenewswire.com//news-release/2023/11/10/2778378/0/en/STADA-and-Alvotech-receive-positive-CHMP-opinion-for-Europe-s-first-ustekinumab-biosimilar-to-Stelara.html
https://endpts.com/hhs-says-stelara-may-be-deselected-from-medicare-negotiations-depending-on-biosimilar-launch/
https://www.fda.gov/news-events/press-announcements/fda-approves-interchangeable-biosimilar-multiple-inflammatory-diseases
https://news.abbvie.com/article_display.cfm?article_id=12621#:~:text=NORTH%20CHICAGO%2C%20Ill.%2C%20Oct,week%2012%20and%20every%208
https://investors.alvotech.com/news-releases/news-release-details/alvotech-provides-update-status-us-biologics-license-application
https://www.globenewswire.com//news-release/2023/09/25/2748356/0/en/Alvotech-Announces-Approval-in-Japan-of-AVT04-ustekinumab-a-Biosimilar-to-Stelara.html
https://www.fiercepharma.com/pharma/abbvies-skyrizi-deals-heavy-blow-jjs-stelara-head-head-ibd-crohns-disease-study
https://www.fiercepharma.com/pharma/sandoz-nearing-official-novartis-split-signs-commercialize-samsungs-stelara-biosimiliar
https://www.fiercepharma.com/pharma/jj-inks-another-stelara-patent-settlement-time-fresenius-kabi-and-formycon
https://www.fiercepharma.com/pharma/johnson-johnson-continues-stelara-biosimilar-settlement-alvotech-teva-deal
https://www.fiercepharma.com/pharma/clocks-ticking-stelara-amgen-jj-ink-patent-settlement
https://www.globenewswire.com/news-release/2023/03/17/2629384/0/en/Samsung-Bioepis-Presents-Phase-1-Study-Results-of-SB17-Ustekinumab-A-Proposed-Biosimilar-to-Stelara-at-2023-AAD-Annual-Meeting.html
https://www.prnewswire.com/news-releases/new-stelara-ustekinumab-long-term-data-support-its-established-safety-profile-in-inflammatory-bowel-disease-and-durable-efficacy-in-ulcerative-colitis-301762191.html
https://www.stada.com/blog/posts/2023/february/ema-confirms-acceptance-of-application-for-avt04-a-proposed-biosimilar-to-stelara-ustekinumab
https://investors.alvotech.com/news-releases/news-release-details/alvotech-and-teva-announce-acceptance-us-biologics-license
https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sues-amgen-over-plan-sell-ulcerative-colitis-drug-similar-stelara-2022-11-30/
https://endpts.com/protecting-its-megablockbuster-janssen-challenges-amgens-stelara-biosimilar-ahead-of-planned-2023-launch/
https://www.prnewswire.com/news-releases/stelara-ustekinumab-demonstrated-sustained-symptomatic-and-corticosteroid-free-remission-through-four-years-in-adults-with-moderately-to-severely-active-ulcerative-colitis-301644223.html
https://www.thepharmaletter.com/article/fda-green-light-for-stelara-in-children-with-active-psa
https://www.prnewswire.com/news-releases/amgen-announces-positive-top-line-results-from-phase-3-study-of-abp-654-biosimilar-candidate-to-stelara-ustekinumab-301527333.html
https://www.europeanpharmaceuticalreview.com/news/164671/stelara-shows-promise-to-treat-gut-diseases-in-new-analyses/
https://www.prnewswire.com/news-releases/new-analyses-suggest-favorable-results-for-stelara-ustekinumab-when-used-as-a-first-line-therapy-for-bio-naive-patients-with-moderately-to-severely-active-crohns-disease-and-ulcerative-colitis-301407438.html
https://www.prnewswire.com/news-releases/janssen-submits-application-seeking-us-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-pediatric-patients-with-juvenile-psoriatic-arthritis-301396106.html
http://www.pharmafile.com/news/589844/janssen-s-bowel-disease-drug-shown-be-safe-use-older-patients
https://www.prnewswire.com/news-releases/new-analysis-presented-by-janssen-at-united-european-gastroenterology-week-uegw-demonstrates-long-term-safety-profile-for-stelara-ustekinumab-in-older-patients-across-approved-indications-301391331.html
http://www.pharmatimes.com/news/ucbs_bimekizumab_data_in_plaque_psoriasis_published_in_the_lancet_1362782
https://www.pharmiweb.com/press-release/2020-11-09/formycon-and-bioeq-announce-launch-of-phase-iii-study-of-fyb202-a-biosimilar-candidate-for-stelara
https://www.clinicaltrialsarena.com/news/janssen-stelara-remission-trial/
https://www.prnewswire.com/news-releases/stelara-ustekinumab-five-year-results-presented-from-long-term-extension-study-of-clinical-response-and-remission-in-patients-with-moderate-to-severe-crohns-disease-301149840.html
http://www.pharmatimes.com/news/fda_and_ema_accept_regulatory_submissions_for_ucbs_bimekizumab_1351158
https://www.businesswire.com/news/home/20200903005319/en/Bio-Thera-Solutions-Initiates-Phase-Clinical-Trial-BAT2206
http://www.pharmafile.com/news/554940/fda-expands-stelara-indication-cover-paediatric-plaque-psoriasis
http://www.pharmafile.com/news/554940/fda-expands-stelara-indication-cover-paediatric-plaque-psoriasis
Market Place
Share 
